[1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
|
[2]KIM DY, PAIK YH, AHN SH, et al.PIVKA-II is a useful tumor marker for recurrent hepatocelluar carcinoma after surgical resection[J].Oncology, 2007, 72 (Suppl 1) :52-57.
|
[3]YANG JJ, WANG P, YANG JZ, et al.Value of contrast-enhanced ultrasonography in diagnosis of intrahepatic cholangiocarcinoma[J].Chin J Med Offic, 2017, 45 (9) :981-982. (in Chinese) 杨金君, 王萍, 杨建忠, 等.超声造影对肝内胆管细胞癌诊断价值[J].临床军医杂志, 2017, 45 (9) :981-982.
|
[4]Pattern of serumα-fetal protein, intereleukin-6 and Golgi protein73 expressed in liver diseases and their diagnostic value on hepatocellular carcinoma[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2017, 11 (4) :339-344. (in Chinese) 张小曼, 魏梅娟, 许正锯, 等.血清甲胎蛋白、白细胞介素-6和高尔基体蛋白73在肝脏疾病中的表达特点及其对肝细胞癌的诊断价值[J/CD].中华实验和临床感染病杂志:电子版, 2017, 11 (4) :339-344.
|
[5]FORNER A, LLOVET JM, BRUIX J.Hepatocellular carcinoma[J].Lancet, 2012, 379 (9822) :1245-1255.
|
[6]DURAZO FA, BLATT LM, COREY WG, et al.Des-gammacarboxy prothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma[J].JGastroenterol Hepatol, 2008, 23 (10) :1541-1548.
|
[7]ERTLE JM, HEIDER D, WICHERT M, et al.A combination ofα-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatoeellular carcinoma[J].Digestion, 2013, 87 (2) :121-131.
|
[8]HUANG SJ, JIANG FF, WANG Y, et al.Diagnostic value of joint detection of AFP and PIVKA-II in hepatocellular carcinoma[J].Labeled Immunoassay Clin Med, 2016, 23 (10) :1134-1138.黄述婧, 姜菲菲, 王颖, 等.AFP与PIVKA-Ⅱ联合检测在原发性肝癌诊断中的应用研究[J].标记免疫分析与临床, 2016, 23 (10) :1134-1138.
|
[9]JI WB, XIAO NJ, LUO Y, et al.Alpha-fetoprotein and desgamma-carboxyprothrombin in the differential diagnosis of hepatocellular carcinoma from other liver tumors[J].Chin J Hepatobiliary Surg, 2016, 22 (3) :145-149. (in Chinese) 纪文斌, 肖年军, 罗英, 等.甲胎蛋白与异常凝血酶原在鉴别诊断肝细胞癌中的价值[J].中华肝胆外科杂志, 2016, 22 (3) :145-149.
|
[10]ZHANG YS, CHU JH, CUI SX, et al.Des-γ-carboxy prothrombin (DCP) as a potential autologous growth factor for the development of hepatocellular carcinoms[J].Cell Physiol Biochem, 2014, 34 (3) :903-915.
|
[11]ZINKIN NT, GRALL F, BHASKAR K, et al.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease[J].Clin Cancer Res, 2008, 14 (2) :470-477.
|